These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15961762)

  • 1. Achieving optimal outcomes after radical prostatectomy.
    Saranchuk JW; Kattan MW; Elkin E; Touijer AK; Scardino PT; Eastham JA
    J Clin Oncol; 2005 Jun; 23(18):4146-51. PubMed ID: 15961762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
    Glickman L; Godoy G; Lepor H
    J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological and functional results of antegrade radical retropubic prostatectomy for the treatment of clinically localised prostate cancer.
    Carini M; Masieri L; Minervini A; Lapini A; Serni S
    Eur Urol; 2008 Mar; 53(3):554-61. PubMed ID: 17683854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robotic radical prostatectomy for elderly patients: probability of achieving continence and potency 1 year after surgery.
    Shikanov S; Desai V; Razmaria A; Zagaja GP; Shalhav AL
    J Urol; 2010 May; 183(5):1803-7. PubMed ID: 20299041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative risk stratification predicts likelihood of concurrent PSA-free survival, continence, and potency (the trifecta analysis) after radical retropubic prostatectomy.
    Pierorazio PM; Spencer BA; McCann TR; McKiernan JM; Benson MC
    Urology; 2007 Oct; 70(4):717-22. PubMed ID: 17991543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing a new, simple scoring system to evaluate oncological and functional outcome after radical prostatectomy.
    Salomon L; Anastasiadis A; Saint F; De La Taille A; Chopin D; Abbou CC
    Scand J Urol Nephrol; 2003; 37(5):392-5. PubMed ID: 14594687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
    Walsh PC
    J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age stratified functional outcomes after laparoscopic radical prostatectomy.
    Rogers CG; Su LM; Link RE; Sullivan W; Wagner A; Pavlovich CP
    J Urol; 2006 Dec; 176(6 Pt 1):2448-52. PubMed ID: 17085126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.
    Carver BS; Bianco FJ; Scardino PT; Eastham JA
    J Urol; 2006 Aug; 176(2):564-8. PubMed ID: 16813890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy.
    Kübler HR; Tseng TY; Sun L; Vieweg J; Harris MJ; Dahm P
    J Urol; 2007 Aug; 178(2):488-92; discussion 492. PubMed ID: 17561133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate-term potency, continence, and survival outcomes of radical prostatectomy for clinically high-risk or locally advanced prostate cancer.
    Loeb S; Smith ND; Roehl KA; Catalona WJ
    Urology; 2007 Jun; 69(6):1170-5. PubMed ID: 17572209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical prostatectomy after previous prostate surgery: clinical and functional outcomes.
    Colombo R; Naspro R; Salonia A; Montorsi F; Raber M; Suardi N; Saccà A; Rigatti P
    J Urol; 2006 Dec; 176(6 Pt 1):2459-63; discussion 2463. PubMed ID: 17085129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.
    Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R
    Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open radical retropubic prostatectomy gives favourable surgical and functional outcomes after transurethral resection of the prostate.
    Palisaar JR; Wenske S; Sommerer F; Hinkel A; Noldus J
    BJU Int; 2009 Sep; 104(5):611-5. PubMed ID: 19298408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study.
    Penson DF; McLerran D; Feng Z; Li L; Albertsen PC; Gilliland FD; Hamilton A; Hoffman RM; Stephenson RA; Potosky AL; Stanford JL
    J Urol; 2005 May; 173(5):1701-5. PubMed ID: 15821561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of moderate dose of postoperative radiation on urinary continence and potency in patients with prostate cancer treated with nerve sparing prostatectomy.
    Formenti SC; Lieskovsky G; Simoneau AR; Skinner D; Groshen S; Chen SC; Petrovich Z
    J Urol; 1996 Feb; 155(2):616-9. PubMed ID: 8558674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer].
    Xylinas E; Misraï V; Comperat E; Renard-Penna R; Vaessen C; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
    Prog Urol; 2009 May; 19(5):285-90. PubMed ID: 19393531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.